Skip to main content

New England Peptide, CIL Ink Manufacturing, Marketing Deal for Quantitative Proteomics

NEW YORK (GenomeWeb News) – New England Peptide and Cambridge Isotope Laboratories today announced they will jointly manufacture and market preloaded resins for synthesizing stable isotope standards for quantitative proteomics.

CIL will provide high purity stable isotope amino acids to NEP who will load the isotopologues onto peptide synthesis resin. It will then perform quality control on the resins and redistribute them to CIL. The firms will co-market and sell the preloaded resins to peptide synthesis labs worldwide.

"We saw this collaboration as an important way to facilitate the synthesis of peptide stable isotope standards," Sam Massoni, president and CEO of NEP, said in a statement. "This product will increase the availability and decrease the cost of SIS peptides, which will help the quantitative proteomics field grow."

Financial and other terms were not disclosed.

Last week, CIL and C2N Diagnostics reached an agreement to provide C2N access to large quantities of highly enriched stable isotopes.

The Scan

Rise of B.1.617.2 in the UK

According to the Guardian, UK officials expect the B.1.617.2 variant to soon be the dominant version of SARS-CoV-2 there.

Anne Schuchat to Retire

Anne Schuchat is retiring after more than 30 years at the US Centers for Disease Control and Prevention, Politico reports.

US to Share More Vaccines

CNN reports that the US will share 20 million doses of the Moderna, Pfizer, and Johnson & Johnson SARS-CoV-2 vaccines with other countries.

PNAS Papers on Gene Therapy Platform, Aspergillus Metabolome, Undernutrition Model Microbiome

In PNAS this week: approach to deliver protein-based treatments to cells, pan-secondary metabolome of Aspergillus, and more.